Clinical development, meet agentic AI.

A new model for clinical development is taking shape — where startup, enrollment, and conduct move in days and months, not years. One platform. Unified workflows, data, and clinical context. Get the full power of  agentic AI across the full trial lifecycle  at your fingertips

A clinical trial participant using Medable's eCOA
Diagram of Medable Agent Platform showing three main areas: Agentic Clinical Development, Agentic Evidence Generation, and Build your own with agent platform, supported by Medable Agent Builder and Clinical Ontology Semantic Layer, with components including Connectors, Skills and Prompts, Knowledge and Clinical context, Human-in-the-loop audit trails, Security with Role Management, and Validation of Agent Performance.
Animated illustration of a woman with shoulder-length brown hair and light skin waving her hand and smiling on a light blue background.

Unlock the agentic advantage

Unify your clinical systems and workflows, and turn data into intelligent, trusted action while reducing manual burden across clinical operations.

Medable’s Agent Platform is purpose-built for clinical development, with deep context across GxP compliance, regulatory requirements, and the operational complexity that general-purpose AI platforms aren't equipped to navigate.

Animated interface of Medable AI generating eCOA screens from a user prompt about a sleep diary questionnaire.

Less risk. More control. eCOA, reimagined.

Medable's agentified eCOA brings AI-powered workflows to every stage of the trial — from build and deployment to study conduct and data review — delivering consistent, high-quality data and stronger participant adherence.

Spanning eConsent, sensors, provisioned devices, and BYOD, Medable offers a unified experience that reduces operational complexity across every touchpoint of the trial.

Clinical outcomes backed by real-world evidence

90%+
eCOA participant adherence

Near-perfect compliance across a 70+ site master protocol.
43%
Reduction in translation
timelines

Half the time to go-live with AI-powered translation.
1 day
Trial build time

From weeks to one business day with Medable Studio.
99%
eCOA adherence in Japan

FPI achieved ahead of schedule across a complex regional rollout.
Animated GIF showing a graphical user interface with text input and a human-in-the-loop feedback process illustrated by highlighted text and interaction icons.

Trusted, traceable, science-ready AI

Autonomous where it can be, human-led where it must be. Clinical judgment, amplified — never replaced.


  • Always traceable: Every automated action logged, explainable, and auditable end-to-end
  • Human-in-the-loop: Critical decisions stay with your team giving you full control
  • Built-for-purpose: Regulatory context built in from day one — not retrofitted after

Built for global regulatory compliance and data integrity

The 1:1:1 vision

1 day study start, 1 day patient enrollment, 1 year study conduct.

An ambitious vision and one Medable is actively building toward. With agentic AI purpose-built for clinical development, we're making meaningful progress toward timelines the industry once thought were out of reach.

The clinical monitoring agent gives us a holistic view, but what really matters is the site. Normally, we find out about enrollments or screen failures through hundreds of emails, easy to miss. Having that site-specific data right when we log in is a real game changer.
Clincal Research Associate
Top 10 Pharma

The latest news

Releases

Medable Introduces AI Agent to Reduce Burden at Research Sites by Assisting Principal Investigators with Oversight of eCOA Data

6 min

Medable Inc., the leading technology platform for AI-powered clinical development, today announced the launch of Agentic AI for research sites to reduce burden and assist principal investigators in oversight and monitoring of eCOA data.

eTMF agent from Medable
Releases

Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes

6 min

TMF Agent significantly improves quality and consistency while drastically reducing the manual effort in document management. It is built on Medable’s Agent Studio, the industry’s first agentic AI platform for clinical development.

Releases

Medable Named a Leader Amid Growing eCOA Adoption

6 min

Everest Group’s 2025 Life Sciences eCOA PEAK Matrix® Assessment highlights Medable eCOA leadership in ease of use, AI innovation, and patient-centered design

See how our Agent Platform can transform your trials.